Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis
A post-hoc analysis
Y. Whitney Cheung
1
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
,
Saskia Middeldorp
1
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
,
Martin H. Prins
2
Department of Clinical Epidemiology, Maastricht University, Maastricht, The Netherlands
,
Akos F. Pap
3
Bayer HealthCare, Wuppertal, Germany
,
Anthonie W. A. Lensing
3
Bayer HealthCare, Wuppertal, Germany
,
Arina J. ten Cate-Hoek
4
Laboratory for Thrombosis and Hemostasis, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands
5
Department of Internal Medicine, Maastricht University Medical Centre, the Netherlands
,
Sabina Villalta
6
Department of Medicine, University Hospital of Treviso, Treviso, Italy
,
Marta Milan
7
Department of Cardiovascular Sciences, University of Padua, Padova, Italy
,
Jan Beyer-Westendorf
8
Center for Vascular Medicine and Department of Medicine III, Division of Angiology, University Hospital ‘Carl Gustav Carus’ Dresden, Dresden, Germany
,
Peter Verhamme
9
Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium
,
Rupert M. Bauersachs
10
Darmstadt Hospital, Department of Vascular Medicine, Darmstadt, Germany
11
University of Mainz, Center of Thrombosis and Haemostasis, Mainz, Germany
,
Paolo Prandoni
7
Department of Cardiovascular Sciences, University of Padua, Padova, Italy